Macrogol 4000 Aurobindo (Macrogol 4000)

Macrogol 4000 is a high‑molecular‑weight polyethylene glycol that is minimally absorbed from the gastrointestinal tract. By retaining water osmotically within the colon, it creates a fluid‑rich environment that softens fecal material, expands the lumen, and stimulates peristaltic activity, thereby facilitating the passage of stool. Its action is localized to the intestine and does not involve systemic absorption.

The appropriate dose of Macrogol 4000 is determined by the prescribing healthcare professional based on the individual’s age, severity of constipation, and response to therapy. Patients should follow the specific instructions provided on the product label or by their clinician and should not adjust the amount without medical advice.

Safety data for Macrogol 4000 in pregnancy and lactation are limited, and the product is generally classified as category unknown. Healthcare providers should evaluate the potential benefits and risks before prescribing it to pregnant or nursing mothers, and use it only if the expected therapeutic advantage justifies possible exposure to the fetus or infant.

To place an order, visit the product page for Macrogol 4000 Aurobindo on the GNH India website (gnhindia.com) and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with stimulant laxatives such as bisacodyl, Macrogol 4000 works by drawing water into the bowel rather than stimulating intestinal muscle contractions, resulting in a gentler, more physiologic effect. It is less likely to cause cramping but may require longer onset time. Osmotic agents like lactulose have a similar mechanism, though Macrogol 4000 typically provides a more rapid and predictable stool softening effect.

Macrogol 4000 should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children. Do not expose the product to excessive heat or humidity, as this may affect its stability and efficacy.

Macrogol 4000 is taken orally, usually dissolved in a measured amount of water or another suitable liquid as directed on the label or by a healthcare professional. The solution should be consumed promptly after preparation to ensure proper dosing. Patients should avoid mixing it with alcoholic beverages or other medications unless advised.

The most serious risks include severe dehydration and electrolyte disturbances, which can occur if the product is over‑used or combined with other laxatives or diuretics. Rarely, an allergic reaction such as rash, swelling, or difficulty breathing may develop. Prompt medical attention is required if any of these severe symptoms appear.

Macrogol 4000 is contraindicated in individuals with known or suspected intestinal obstruction, perforation, or severe inflammatory bowel disease. It should also be avoided in patients with hypersensitivity to polyethylene glycol or any of the product’s excipients. Persons with uncontrolled electrolyte imbalances should not use the medication until the condition is corrected.